Home/EpiBiologics/Ann Lee-Karlon, Ph.D.
AL

Ann Lee-Karlon, Ph.D.

Chief Executive Officer and President

EpiBiologics

EpiBiologics Pipeline

DrugIndicationPhase
c-MET Degrading Bispecific AntibodyOncology (likely various solid tumors)Preclinical